Sargent Investment Group’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,817	Closed	-$299K	–	199
2021 Q2	$299K	Buy	+3,817	New	+$299K	0.07%	158
2021 Q1	–	Sell	-2,621	Closed	-$220K	–	188
2020 Q4	$220K	Buy	+2,621	New	+$220K	0.07%	159